ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 630375 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 630375; 2) Community: the network communities that were significantly associated with the response to NSC 630375; 3) Molecule: the relationships between components within communities and NSC 630375; 4) MDR: the compounds that were significantly associated with the NSC 630375.

NSC Compound Enrichment Correlation
NSC 718170 Null 0.0459335986102865 -0.085079373
NSC 732317 6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide 0.0459335986102865 -0.17615332
NSC 633530 1H-Pyrido[3,4-b]indol-1-one, 2,3,4,9-tetrahydro-2-[4-(4- phenyl-1-piperazinyl)butyl]-9-methyl- 0.0459335986102872 -0.30099094
NSC 633713 N.ALPHA.-(4-AMINO-4-DEOXYLPTEROYL)-N.DELTA.-HEMIPHTHALOYL-L-ORNITHINE 0.0459335986102872 -0.2983235
NSC 635000 Null 0.0459335986102872 -0.2492913
NSC 641177 Null 0.0459335986102872 -0.39143848
NSC 641233 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- 0.0459335986102872 -0.30171385
NSC 641297 ANTINEOPLASTIC-641297 0.0459335986102872 -0.15417056
NSC 653625 Null 0.0459335986102872 -0.34720302
NSC 658142 2-(1-(4-(2-Pyridyl)piperazino))naphthazarin 0.0459335986102872 -0.32959967
Total:86  Current:77    [First] [Prev] [Next] [Last]